Construction and Application of Integrated Diagnosis and Treatment System for Mycoplasma Pneumoniae Pneumonia in Children: A Regional Perspective

Hua Jin; Zheng Wang; Fujian Ta; Wuqiong Zhang; Wei Wei; Jinhua Yuan; Aimin Sun; Qian Zhao; Ruorui Wang; Baoxian Lu; Jialin Liu

doi:10.62051/jy3b2w98

Authors

Hua Jin
Zheng Wang
Fujian Ta
Wuqiong Zhang
Wei Wei
Jinhua Yuan
Aimin Sun
Qian Zhao
Ruorui Wang
Baoxian Lu
Jialin Liu

DOI:

https://doi.org/10.62051/jy3b2w98

Keywords:

Mycoplasma pneumoniae pneumonia, integrated diagnosis and treatment system, interdisciplinary medical care, personalized treatment

Abstract

This paper aims to explore the construction and application of an integrated diagnosis and treatment system for Mycoplasma pneumoniae pneumonia (MPP) in children within a specific region. MPP is a common respiratory infection among children, posing challenges in diagnosis and uncertainty in treatment outcomes. By integrating modern technologies and interdisciplinary medical resources, this paper proposes a comprehensive system aimed at enhancing diagnostic accuracy, personalized treatment effects, and optimizing the efficiency of medical resource utilization. Through theoretical discussion, methodological descriptions, and practical case analyses, the paper demonstrates the system's practical application and potential for future development.

Downloads

Download data is not yet available.

References

[1] Ghimire, M., S. K. Bhattacharya, and J. P. Narain. "Pneumonia in South-East Asia region: public health perspective." Indian Journal of Medical Research 135.4 (2012): 459-468.

[2] Aston, Stephen J. "Pneumonia in the developing world: C haracteristic features and approach to management." Respirology 22.7 (2017): 1276-1287.

[3] Rasmussen, Z., A. Pio, and P. Enarson. "Case management of childhood pneumonia in developing countries: recent relevant research and current initiatives." The International Journal of Tuberculosis and Lung Disease 4.9 (2000): 807-826.

[4] Wang, Hua, et al. "A versatile loop-mediated isothermal amplification microchip platform for Streptococcus pneumoniae and Mycoplasma pneumoniae testing at the point of care." Biosensors and Bioelectronics 126 (2019): 373-380.

[5] Sabbagh, Waad Abdulaziz, et al. "Perspective of Pneumonia in the Health-Care Setting." Journal of Pharmaceutical Research International 36.7 (2024): 51-58.

[6] Georgakopoulou, Vasiliki Epameinondas, et al. "Exploring the pathogenetic mechanisms of Mycoplasma pneumoniae." Experimental and Therapeutic Medicine 28.1 (2024): 1-11.

[7] Lapa, S. A., et al. "Development of multiplex RT-PCR with immobilized primers for identification of infectious human pneumonia pathogens." Molecular Biology 55 (2021): 828-838.

[8] Atkinson, Maria, et al. "Effective treatment strategies for paediatric community-acquired pneumonia." Expert opinion on pharmacotherapy 8.8 (2007): 1091-1101.